Current use of hydroxychloroquine was associated with a significantly decreased risk for cardiovascular events among patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE),
Lupus patients who take their medications lower their diabetes risk
Adhering to antimalarial treatment offers some protection to patients with systemic lupus erythematosus (SLE) from developing type 2 diabetes mellitus (T2DM), according to new research.
Patients who took at least 90% of their prescribed antimalarial doses were 39% less likely to develop T2DM than patients who discontinued antimalarial therapy. Patients who took less than 90% of their prescribed doses but didn’t discontinue treatment were 22% less likely to develop T2DM.
Pregnant SLE patients discontinue medication when they shouldn't
Marital status and age of SLE diagnosis: the potential for differences related to sex and gender
Lupus Psychosis: Rare but Treatable
Lupus Overlap in Scleroderma Patients Does Not Seem to Affect Survival
Patients with both scleroderma and systemic lupus erythematosus (SLE) are younger at diagnosis, are more often women, and have less skin manifestations, but most importantly, show similar survival rates as those without lupus, according to a study.
The study, “Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome,” was published in The Journal of Rheumatology.
